178 related articles for article (PubMed ID: 29781244)
1. OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients.
Muriel J; Margarit C; Planelles B; Serralta MJ; Puga C; Inda MD; Cutillas E; Morales D; Horga JF; Peiró AM
Ann N Y Acad Sci; 2018 Aug; 1425(1):82-93. PubMed ID: 29781244
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients.
Muriel J; Margarit C; Barrachina J; Ballester P; Flor A; Morales D; Horga JF; Fernández E; Peiró AM
Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):439-448. PubMed ID: 30549211
[TBL] [Abstract][Full Text] [Related]
3. Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach.
Escorial M; Muriel J; Agulló L; Zandonai T; Margarit C; Morales D; Peiró AM
Minerva Anestesiol; 2024 May; 90(5):386-396. PubMed ID: 38619184
[TBL] [Abstract][Full Text] [Related]
4. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
[TBL] [Abstract][Full Text] [Related]
5. OPRM1 Gene Interaction with Sleep in Chronic Pain Patients Treated with Opioids.
Margarit C; Ballester P; Inda MD; Roca R; Gomez L; Planelles B; Ajo R; Morales D; Peiro AM
Pain Physician; 2019 Jan; 22(1):97-107. PubMed ID: 30700073
[TBL] [Abstract][Full Text] [Related]
6. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
[TBL] [Abstract][Full Text] [Related]
8. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
9. A brief review of the genetics and pharmacogenetics of opioid use disorders.
Berrettini W
Dialogues Clin Neurosci; 2017 Sep; 19(3):229-236. PubMed ID: 29302220
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
11. OPRM1 and COMT Gene-Gene Interaction Is Associated With Postoperative Pain and Opioid Consumption After Orthopedic Trauma.
Khalil H; Sereika SM; Dai F; Alexander S; Conley Y; Gruen G; Meng L; Siska P; Tarkin I; Henker R
Biol Res Nurs; 2017 Mar; 19(2):170-179. PubMed ID: 27903758
[TBL] [Abstract][Full Text] [Related]
12. Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.
Wang XS; Song HB; Chen S; Zhang W; Liu JQ; Huang C; Wang HR; Chen Y; Chu Q
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):752-758. PubMed ID: 26489634
[TBL] [Abstract][Full Text] [Related]
13. Gender based differences, pharmacogenetics and adverse events in chronic pain management.
Planelles B; Margarit C; Inda MD; Ballester P; Muriel J; Barrachina J; Ajo R; Esteban MD; Peiró AM
Pharmacogenomics J; 2020 Apr; 20(2):320-328. PubMed ID: 31745220
[TBL] [Abstract][Full Text] [Related]
14. OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859.
Kaya-Akyüzlü D; Özkan-Kotiloğlu S; Danışman M; Bal C
Neurosci Lett; 2024 Jun; 834():137846. PubMed ID: 38821204
[TBL] [Abstract][Full Text] [Related]
15. Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study.
Barrachina J; Margarit C; Muriel J; López-Gil S; López-Gil V; Vara-González A; Planelles B; Inda MD; Morales D; Peiró AM
Sci Rep; 2022 Jun; 12(1):10126. PubMed ID: 35710811
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of OPRM1.
Crist RC; Berrettini WH
Pharmacol Biochem Behav; 2014 Aug; 123():25-33. PubMed ID: 24201053
[TBL] [Abstract][Full Text] [Related]
17. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
18. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of OPRM1 and ABCB1 single-nucleotide polymorphisms to oxycodone response in postoperative pain.
Zwisler ST; Enggaard TP; Mikkelsen S; Verstuyft C; Becquemont L; Sindrup SH; Brosen K
J Clin Pharmacol; 2012 Feb; 52(2):234-42. PubMed ID: 21383334
[TBL] [Abstract][Full Text] [Related]
20. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
